Anti-IGFR1 antibody therapeutic combinations

Details for Australian Patent Application No. 2004292554 (hide)

Owner Schering Corporation

Inventors Wang, Yan; Bishop, Walter R.; Pachter, Jonathan A.

Agent Griffith Hack

Pub. Number AU-B-2004292554

PCT Pub. Number WO2005/052005

Priority 60/524,732 21.11.03 US

Filing date 19 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 28 May 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/052005 Priority application(s): WO2005/052005

28 May 2009 Application Accepted

  Published as AU-B-2004292554

24 September 2009 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004292555-Estrogen receptor modulators

2004292547-Methods for purifying pertussis toxin and peptides useful therefor